FDA.reportPublic FDA data

0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]

RxCUI
2641667
RxNorm name
0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]
Display name
0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]
Full name
0.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761071Hyrimozadalimumab-adaz351(k) InterchangeableRx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1ac7d061-3380-468c-b077-c05f8dfbc8290.8 ML adalimumab-adaz 100 MG/ML Prefilled Syringe [Hyrimoz]SBD13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc829Hyrimoz 80 MG per 0.8 ML Prefilled SyringeSY13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017
1ac7d061-3380-468c-b077-c05f8dfbc829Hyrimoz 80 MG in 0.8 ML Prefilled SyringePSN13These highlights do not include all the information needed to use HYRIMOZ ® safely and effectively. See full prescribing information for HYRIMOZ. HYRIMOZ (adalimumab-adaz) injection, for subcutaneous use Initial U.S. Approval: 2018 HYRIMOZ (adalimumab-adaz) is biosimilar* to HUMIRA ® (adalimumab)20251017